These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25605201)

  • 61. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
    PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
    Zhang T; Cao C; Wu D; Liu L
    Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
    Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
    Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
    Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
    Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
    Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.
    Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N
    Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
    PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
    Xu K; Gao J; Yang X; Yao Y; Liu Q
    Oncol Rep; 2013 Jun; 29(6):2211-8. PubMed ID: 23545718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy.
    Cheung ST; Ho JC; Leung KL; Chen X; Fong DY; So S; Fan ST
    Neoplasia; 2005 Feb; 7(2):91-8. PubMed ID: 15810144
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
    Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
    Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
    Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
    J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.